NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
Back to search
Official data from USPTO
ASAP ASCENDIS SIGNATURE ACCESS PROGRAM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/02/2024
Trademark type
Combined
Nice classes
36, 41, 44
Filing date
03/03/2021
Registration date
04/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
04/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
99
Owner location
Hellerup, DK
Examiner
PENDLETON, CAROLYN A
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "ASAP", with small diamonds between the letters, and the stylized wording "ASCENDIS SIGNATURE ACCESS PROGRAM" underneath.
Holders and representatives
Holders
Ascendis Pharma A/S
Representatives
Shannon Marie McKeon DYKEMA GOSSETT PLLC
Technical classification
Nice Classes
Class 36Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Patient support programadvancement of funds for covering pharmaceutical and medical expenses and providing information about eligibility for financial assistance provided through patient benefits programs; pharmaceutical and pharmacy benefit management servicesprovision of information for patients in relation to obtaining benefits relating to medical treatment and pharmaceuticals
Class 41
Educational servicesconducting educational programs for patients and healthcare providers in the field of growth hormone deficiencyendocrine disordersbone and skeletal disorders; educational servicestraining patients and healthcare providers in the field of self-administering medications
Class 44
Patient support programproviding health care information to patients and healthcare providers in the field of growth hormone deficiencyendocrine disordersbone and skeletal disorders diagnosis and treatment including providing information on self-administering medications; administering a quick start patient assistance program to provide patients with limited free supplies of drugs to initiate therapy while obtaining benefits or insurance coverage
Publications
History of USPTO decisions and trademark events.
38 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2024
CHPB
POST PUBLICATION AMENDMENT - ENTERED
02/06/2024
ISPO
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
02/06/2024
APET
ASSIGNED TO PETITION STAFF
02/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/16/2024
PUBO
PUBLISHED FOR OPPOSITION
01/16/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
12/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/12/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/12/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/12/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/12/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/14/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/26/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
09/11/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/06/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/08/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/13/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
12/19/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/30/2022
DOCK
ASSIGNED TO EXAMINER
11/29/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/23/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/19/2022
GNSL
LETTER OF SUSPENSION E-MAILED
04/19/2022
CNSL
SUSPENSION LETTER WRITTEN
04/19/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/23/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/23/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/23/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/26/2021
GNRT
NON-FINAL ACTION E-MAILED
09/26/2021
CNRT
NON-FINAL ACTION WRITTEN
09/26/2021
DOCK
ASSIGNED TO EXAMINER
09/25/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/02/2021
NWAP
NEW APPLICATION ENTERED
03/06/2021
Continuous trademark protection
Get notified about every new filing that threatens ASAP ASCENDIS SIGNATURE ACCESS PROGRAM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.